Multiple Assemblies exist for SMTL entry 6q9s
HDMX (14-111; C17S) COMPLEXED WITH COMPOUND 14 AT 2.4A: Structural states of Hdm2 and HdmX: X-ray elucidation of adaptations and binding interactions for different chemical compound classes; X-RAY DIFFRACTION 2.40 Å

	SMTL ID 6q9s.1 Ligands 3-[[6-chloranyl-3-[3-[(1~{S})-1-(2,4-dichlorophenyl)ethyl]-5-phenyl-imidazol-4-yl]-1~{H}-indol-2-yl]carbonylamino]-4-[4-(2-oxidanylidene-1,3-oxazinan-3-yl)piperidin-1-yl]benzoic acid; 1,4,7,10,13,16-HEXAOXACYCLOOCTADECANE; SULFATE ION; SODIUM ION Polypeptides Protein Mdm4 Oligo-state monomer
	SMTL ID 6q9s.2 Ligands 3-[[6-chloranyl-3-[3-[(1~{S})-1-(2,4-dichlorophenyl)ethyl]-5-phenyl-imidazol-4-yl]-1~{H}-indol-2-yl]carbonylamino]-4-[4-(2-oxidanylidene-1,3-oxazinan-3-yl)piperidin-1-yl]benzoic acid; 1,4,7,10,13,16-HEXAOXACYCLOOCTADECANE; SULFATE ION; SODIUM ION Polypeptides Protein Mdm4 Oligo-state monomer
	SMTL ID 6q9s.3 Ligands 3-[[6-chloranyl-3-[3-[(1~{S})-1-(2,4-dichlorophenyl)ethyl]-5-phenyl-imidazol-4-yl]-1~{H}-indol-2-yl]carbonylamino]-4-[4-(2-oxidanylidene-1,3-oxazinan-3-yl)piperidin-1-yl]benzoic acid; 1,4,7,10,13,16-HEXAOXACYCLOOCTADECANE; SULFATE ION Polypeptides Protein Mdm4 Oligo-state monomer